Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes

Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen

doi:10.1128/JCM.40.8.3047-3049.2002

Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes

J Clin Microbiol. 2002 Aug;40(8):3047-9. doi: 10.1128/JCM.40.8.3047-3049.2002.

Authors

Jia-Horng Kao¹, Pei-Jer Chen, Ming-Yang Lai, Ding-Shinn Chen

Affiliation

¹ Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan. kjh@ha.mc.ntu.edu.tw

Abstract

Of 368 hepatitis B virus (HBV)-infected intravenous drug users, 144 (39%) were positive for antibody to hepatitis D virus (anti-HDV). Anti-HDV-positive HBV carriers had a lower rate of positivity for HBV DNA than did anti-HDV-negative carriers (52 versus 73%, respectively). From 1986 to 1997, the average rate of decrease in the prevalence of HDV infection in this population was 4.7%/year.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Genotype
Hepatitis Antibodies / blood
Hepatitis B / complications
Hepatitis B / epidemiology*
Hepatitis B / virology
Hepatitis B virus / classification*
Hepatitis B virus / genetics
Hepatitis B virus / immunology
Hepatitis D / epidemiology*
Hepatitis D / virology
Hepatitis Delta Virus / classification*
Hepatitis Delta Virus / genetics
Hepatitis Delta Virus / immunology
Humans
Male
Prevalence
Substance Abuse, Intravenous / complications*
Taiwan / epidemiology

Substances

Hepatitis Antibodies